主动脉瓣狭窄在心力衰竭全谱中的影响与预后意义
结果显示,随主动脉瓣狭窄严重程度增加,不良结局呈阶梯式上升,且该关联在射血分数保留、轻度降低和降低的心衰亚型中一致;重度主动脉瓣狭窄患者2年内仅59.5%接受主动脉瓣置换。
要点
- 心衰患者中重度主动脉瓣狭窄占6.5%,中度占5.5%,低梯度占2.5%。
- 相比无主动脉瓣狭窄者,重度主动脉瓣狭窄患者不良结局调整后HR达6.20(95%CI 5.74至6.69)。
- 重度主动脉瓣狭窄心衰患者2年内仅59.5%接受主动脉瓣置换,治疗缺口明显。
核心结论
- 主动脉瓣狭窄在心衰患者中常见,即使在非重度阶段也与全心衰谱系的长期不良结局显著相关。
- 高死亡风险与干预不足提示存在重大治疗缺口,需前瞻性试验评估早期干预策略。
研究设计与样本
- 主动脉瓣狭窄按指南标准分为轻度、中度、低梯度或重度;采用Cox回归按心衰亚型分层并调整临床混杂因素。
- 主要终点为无事件生存,定义为全因死亡或主动脉瓣置换。
主要发现
- 中度主动脉瓣狭窄占5.5%,低梯度占2.5%,重度占6.5%;射血分数保留的心衰在各主动脉瓣狭窄级别中均为最常见亚型。
- 相比无主动脉瓣狭窄者,中度主动脉瓣狭窄调整后HR为2.20(95%CI 2.00至2.41),低梯度为3.32(95%CI 2.97至3.72),重度为6.20(95%CI 5.74至6.69)。
- 上述关联在射血分数保留、轻度降低和降低的心衰中一致。
- 重度主动脉瓣狭窄心衰患者2年内接受主动脉瓣置换的比例为59.5%(95%CI 57%至62%)。
临床怎么用
- 对心衰患者应评估是否合并主动脉瓣狭窄及其严重程度,非重度阶段亦需关注预后风险。
- 对符合指南指征的重度主动脉瓣狭窄心衰患者,应识别并处理未行主动脉瓣置换的治疗缺口。
局限性
- 为回顾性队列研究,可能存在残余混杂。
- 单中心数据来源,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic stenosis (AS) frequently coexists with heart failure (HF), but its prevalence, prognostic impact and management across the full HF spectrum remain incompletely characterised. METHODS: In this retrospective cohort study, we analysed 22 906 patients with HF undergoing echocardiography between 2010 and 2020. AS was classified as mild, moderate, low-gradient (LG) or severe according to guideline criteria. Outcomes were assessed using Cox regression, stratified by HF subtype and adjusted for clinical confounders. The primary endpoint was event-free survival, defined as all-cause mortality or aortic valve replacement (AVR). RESULTS: Moderate AS was present in 5.5%, LG AS in 2.5% and severe AS in 6.5% of HF patients, with HF with preserved ejection fraction (HFpEF) being the most common HF subtype across all AS grades. Increasing AS severity was associated with a stepwise increase in adverse outcomes compared with HF patients without AS (adjusted HR 2.20 (95% CI 2.00 to 2.41) for moderate AS; 3.32 (95% CI 2.97 to 3.72) for LG AS and 6.20 (95% CI 5.74 to 6.69) for severe AS). These associations were consistent across HFpEF, HF with mildly reduced EF and HF with reduced EF. Despite established guideline indications, only 59.5% (95% CI 57% to 62%) of HF patients with severe AS underwent AVR within 2 years. CONCLUSIONS: AS is common in HF and is associated with substantially worse long-term outcomes across all HF subtypes, even at non-severe stages. The high mortality risk and frequent lack of intervention highlight major treatment gaps and underscore the need for prospective trials evaluating earlier intervention strategies.
引用
- Heitzinger, Torrefranca, Koschatko, et al. Impact and prognostic implications of aortic stenosis across the heart failure spectrum: a cohort study. Heart. 2026. PMID: 41565460. doi:10.1136/heartjnl-2025-326808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。